Sec Form 13D Filing - Hudson Executive Capital LP filing for CANTALOUPE INC (CTLP) - 2021-02-26

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 12)

USA Technologies, Inc.

(Name of Issuer)

Common Stock, no par value

(Title of Class of Securities)

90328S500

(CUSIP Number)

Michael D. Pinnisi

Hudson Executive Capital LP

c/o Cadwalader, Wickersham & Taft LLP

200 Liberty Street

New York, NY 10281

(212) 521-8495

with a copy to:

Richard M. Brand
Braden McCurrach

Cadwalader, Wickersham & Taft LLP

200 Liberty Street

New York, NY 10281

(212) 504-6000

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

February 24, 2021

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ☐

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule.13d-7 for other parties to whom copies are to be sent.

ITEM 1. SECURITY AND ISSUER

This Amendment No. 12 to Schedule 13D (this “Amendment No. 12”) relates to the Schedule 13D filed on May 20, 2019 (the “Initial 13D” and, as amended and supplemented through the date of this Amendment No. 12, collectively, the “Schedule 13D”) by the Reporting Persons, relating to the common stock, no par value (the “Shares”), of USA Technologies, Inc., a company organized under the laws of the State of Pennsylvania (the “Company”). Capitalized terms used but not defined in this Amendment No. 12 shall have the meanings set forth in the Schedule 13D.

ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION

Item 3 is hereby amended and supplemented by adding the following information:

The information set forth in Item 4 hereof is hereby incorporated by reference into this Item 3, as applicable. The source of funding for the transactions pursuant to which the Reporting Persons obtained beneficial ownership of the Shares was derived from the respective capital of the HEC Funds.

ITEM 4. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION

Item 4 is hereby amended and supplemented by adding the following information:

On February 24, 2021, the HEC Funds entered into subscription agreements (the “Subscription Agreements”) with the Company for the purchase of an aggregate of 975,000 Shares at $9.60 per Share (the “Purchase Price”), for an aggregate purchase price of $9,360,000. The HEC Funds are purchasing the shares in a private placement exempt from the registration requirements under the Securities Act of 1933 (the “Private Placement”) for the same Purchase Price and on the same terms as the other institutional investors participating in the Private Placement. The Private Placement is expected to close on or about March 1, 2021, subject to customary closing conditions.

The foregoing summary description of the Subscription Agreements does not purport to be complete and is qualified in its entirety by reference to the full text of the Subscription Agreements, the form of which is filed as Exhibit 99.7 and is incorporated herein by reference in its entirety.

ITEM 5. INTEREST IN SECURITIES OF THE ISSUER

Item 5 is hereby amended and supplemented by adding the following information:

(a), (b) Hudson Executive, as the investment adviser to the HEC Funds, and Management GP, as the general partner of Hudson Executive, may be deemed to beneficially own and share power to vote or direct the vote of (and share power to dispose or direct the disposition of) 11,995,765 Shares, which represents 16.9% of the issued and outstanding based on 71,016,404 outstanding Shares, which includes 65,286,404 Shares outstanding as disclosed in the Form of Subscription Agreement filed as Exhibit 10.1 to the Current Report on Form 8-K filed by the Company on February 25, 2021 (the “Form 8-K”) and 5,730,000 Shares issuable in connection with the closing of the Private Placement as described in the Form 8-K.

By virtue of his role with respect to Hudson Executive and Management GP, Mr. Braunstein may be deemed to share power to vote or direct the vote of (and share power to dispose or direct the disposition of) 11,995,765 Shares. Mr. Braunstein has the sole power to vote or direct the vote of (and dispose or direct the disposition of) 135,409 Shares issuable upon (i) the vesting of 15,409 Restricted Stock Units (“RSUs”) granted to him and (ii) the vesting and exercise of 120,000 non-qualified stock options granted to him. Mr. Braunstein beneficially owns an aggregate of 12,131,174 Shares, which represents 17.0% of the issued and outstanding based on 71,151,813 outstanding Shares, which includes 65,286,404 Shares outstanding as disclosed in the Form of Subscription Agreement filed as Exhibit 10.1 to the Form 8-K, 5,730,000 shares issuable in connection with the closing of the Private Placement as described in the Form 8-K and 135,409 shares issuable in connection with the vesting of RSUs and non-qualified stock options granted to Mr. Braunstein.

(c) Except as described in Item 4 above, none of the Reporting Persons has effected any transactions in the Shares during the past 60 days.

(d) The HEC Funds have the right to receive dividends from, and the proceeds from the sale of, the 11,995,765 Shares held by the HEC Funds. Mr. Braunstein will have the right to receive dividends from, and the proceeds from the sale of, any Shares owned in his individual capacity. No other person is known to the Reporting Persons to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Shares reported in this Amendment No. 12.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: February 26, 2021